Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Solveig Ericson"'
Publikováno v:
Journal of the Association of Genetic Technologists. 30(1)
A 44-year-old female was diagnosed in the chronic phase of chronic myelogenous leukemia (CML) and was confirmed to be Philadelphia chromosome positive by a bone marrow cytogenetic study. No additional cytogenetic abnormalities were found. The patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff2aade800251710b815ac70d3d38b94
https://pubmed.ncbi.nlm.nih.gov/15340178
https://pubmed.ncbi.nlm.nih.gov/15340178
Autor:
Michael R. Savona, Ian W. Flinn, Stuart Goldberg, Robert Leon Robles, David Rizzieri, Jerald P. Radich, Michael J. Mauro, Solveig Ericson, Sandy Yi, Jorge E. Cortes
Publikováno v:
Journal of Clinical Oncology. 30:TPS6636-TPS6636
TPS6636 Background: With more-potent tyrosine kinase inhibitors, increasingly sensitive methods are required to monitor treatment response and quantify minimal residual disease (MRD). Molecular monitoring is recommended by National Comprehensive Canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a31bb933838a1b1187e214878ca1d11
https://doi.org/10.1200/jco.2012.30.15_suppl.tps6636
https://doi.org/10.1200/jco.2012.30.15_suppl.tps6636
Autor:
Matthews Juma, Solveig Ericson, Dawn Fun Eng, Sandip Acharya, Darshan Wariabharaj, Tina Owugah, Bettine Avenia, Oleg Zernovak
Publikováno v:
Journal of Clinical Oncology. 30:TPS6638-TPS6638
TPS6638 Background: Family planning decisions for cancer patients of childbearing age are impacted by their diagnosis. IM and NIL are category D drugs (demonstrated risk to the fetus based on mechanism of action and findings in animals; however, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84d6402b5df8b1495823b27d3fce047a
https://doi.org/10.1200/jco.2012.30.15_suppl.tps6638
https://doi.org/10.1200/jco.2012.30.15_suppl.tps6638